These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9506763)

  • 1. The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas.
    Cetta F; Chiappetta G; Melillo RM; Petracci M; Montalto G; Santoro M; Fusco A
    J Clin Endocrinol Metab; 1998 Mar; 83(3):1003-6. PubMed ID: 9506763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
    Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
    Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
    Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
    Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas.
    Lee CH; Hsu LS; Chi CW; Chen GD; Yang AH; Chen JY
    J Clin Endocrinol Metab; 1998 May; 83(5):1629-32. PubMed ID: 9589668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations in thyroid carcinoma associated with familial adenomatous polyposis: clinical implications and suggestions for early detection.
    Cetta F; Olschwang S; Petracci M; Montalto G; Baldi C; Zuckermann M; Mariani Costantini R; Fusco A
    World J Surg; 1998 Dec; 22(12):1231-6. PubMed ID: 9841749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?
    Sugg SL; Zheng L; Rosen IB; Freeman JL; Ezzat S; Asa SL
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3360-5. PubMed ID: 8784097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid carcinomas in RET/PTC transgenic mice.
    Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL
    Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study.
    Soravia C; Sugg SL; Berk T; Mitri A; Cheng H; Gallinger S; Cohen Z; Asa SL; Bapat BV
    Am J Pathol; 1999 Jan; 154(1):127-35. PubMed ID: 9916927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RET/PTC activation in hyalinizing trabecular tumors of the thyroid.
    Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G
    Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.
    Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A
    Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
    Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
    Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
    Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.
    Mayr B; Pötter E; Goretzki P; Rüschoff J; Dietmaier W; Hoang-Vu C; Dralle H; Brabant G
    Br J Cancer; 1998 Mar; 77(6):903-6. PubMed ID: 9528832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RET oncogene activation in papillary thyroid carcinoma.
    Tallini G; Asa SL
    Adv Anat Pathol; 2001 Nov; 8(6):345-54. PubMed ID: 11707626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
    Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
    Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.
    Nikiforov YE; Rowland JM; Bove KE; Monforte-Munoz H; Fagin JA
    Cancer Res; 1997 May; 57(9):1690-4. PubMed ID: 9135009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.
    Liu RT; Chou FF; Wang CH; Lin CL; Chao FP; Chung JC; Huang CC; Wang PW; Cheng JT
    Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation.
    Bounacer A; Wicker R; Caillou B; Cailleux AF; Sarasin A; Schlumberger M; Suárez HG
    Oncogene; 1997 Sep; 15(11):1263-73. PubMed ID: 9315093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant.
    Thomas GA; Bunnell H; Cook HA; Williams ED; Nerovnya A; Cherstvoy ED; Tronko ND; Bogdanova TI; Chiappetta G; Viglietto G; Pentimalli F; Salvatore G; Fusco A; Santoro M; Vecchio G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4232-8. PubMed ID: 10566678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rearrangement of the RET gene in papillary thyroid carcinoma].
    Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.